ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Dr Reddy's Laboratories chairman Satish Reddy warned India against accepting regulatory data protection that weakens its generics industry. He discussed India's innovation gap with China, AI-driven drug discovery, and reforms needed to accelerate R&D.
Tap to vote and see what everyone thinks.
Summary by ByteBrief